# CP Pharmaceuticals Limited, Wrexham, United Kingdom – FDA Inspections

Source: https://www.keypedia.com/companies/cp-pharmaceuticals-limited/23bc92cd-c46a-49fb-b7f0-9ad587214c9d

> Inspection records and compliance data for CP Pharmaceuticals Limited in Wrexham. 4 FDA inspections on record (2 OAI), last inspected October 13, 2015.

---

## Details

- Name: CP Pharmaceuticals Limited
- FEI Number: 3003369660
- Facility Type: Sterile Drug Manufacturer
- Address Line 1: Ash Road North
- City: Wrexham
- Country Name: United Kingdom
- Address: Ash Road North, Wrexham, United Kingdom
- Country: United Kingdom

## Related Documents

- Canada Inspection - CP Pharmaceuticals Limited - Inspection #83717 - 2022-09-12 — source: Canada, date: September 12, 2022
- Canada Inspection - CP Pharmaceuticals Limited - Inspection #75783 - 2020-07-20 — source: Canada, date: July 20, 2020
- Canada Inspection - CP Pharmaceuticals Limited - Inspection #69894 - 2017-02-14 — source: Canada, date: February 14, 2017
- [483 - CP Pharmaceuticals Limited - 2015-10-13](https://www.keypedia.com/records/483/cp-pharmaceuticals-limited/b4fc5197-ae5a-4815-bd2f-947ab1185b91) — source: FDA, date: October 13, 2015
- [FDA Inspection 948044 - CP Pharmaceuticals Limited - 2015-10-13](https://www.keypedia.com/records/fda_inspections/cp-pharmaceuticals-limited/d9955946-83e0-447c-831e-ef2ec01361e0) — classification: Official Action Indicated (OAI), source: FDA, date: October 13, 2015
- Canada Inspection - CP Pharmaceuticals Limited - Inspection #11062 - 2015-05-11 — source: Canada, date: May 11, 2015
- Canada Inspection - CP Pharmaceuticals Limited - Inspection #11047 - 2015-05-11 — source: Canada, date: May 11, 2015
- FDA Inspection 853032 - CP Pharmaceuticals Limited - 2013-09-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 10, 2013
- Canada Inspection - CP Pharmaceuticals Limited - Inspection #871 - 2013-07-01 — source: Canada, date: July 1, 2013
- FDA Inspection 724836 - CP Pharmaceuticals Limited - 2011-05-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 13, 2011
- [FDA Inspection 676852 - CP Pharmaceuticals Limited - 2010-07-29](https://www.keypedia.com/records/fda_inspections/cp-pharmaceuticals-limited/59726d80-96d0-4c6b-8f72-4739741c0690) — classification: Official Action Indicated (OAI), source: FDA, date: July 29, 2010

## Related Companies

- [SGS Laboratoires de la Qualite et Conformite Inc.](https://www.keypedia.com/companies/sgs-laboratoires-de-la-qualite-et-conformite-inc/09168f00-5569-45a0-b5cd-ebe9c4746890)
- [Grunenthal GmbH](https://www.keypedia.com/companies/grunenthal-gmbh/3e05c6cb-e0e7-4762-ac35-83e561b6ad85)
- [AG Hair Ltd.](https://www.keypedia.com/companies/ag-hair-ltd/01bf64b2-07fa-4705-8e76-d991085b5df5)
- [Deciem Inc.](https://www.keypedia.com/companies/deciem-inc/f5212563-b6d0-47c7-ba2e-dc823e5f68dd)
- [Trimel Pharmaceuticals Corporation](https://www.keypedia.com/companies/trimel-pharmaceuticals-corporation/4ab689e5-cfb7-47dd-9cba-85556b0fe4eb)
- [Capcium Inc.](https://www.keypedia.com/companies/capcium-inc/32d767ac-f991-4792-83e0-ed457d874800)
- [SCM Pharma Limited](https://www.keypedia.com/companies/scm-pharma-limited/b622bceb-6282-485b-a717-acf479eb7d28)
- [Max Pharma Canada](https://www.keypedia.com/companies/max-pharma-canada/2b97973b-1f5d-4446-b5a3-67c3a2bef6f5)
- [Swabplus, L.P.](https://www.keypedia.com/companies/swabplus-lp/628a618d-9bd4-48cb-a4f5-462dfdc84b7b)
- [Nelson Laboratories Fairfield, Inc.](https://www.keypedia.com/companies/nelson-laboratories-fairfield-inc/8a60e01d-bc82-4e1c-8a26-e9ae7f82475e)

## Related Officers

- [Alex J. Wild](https://www.keypedia.com/people/alex-j-wild/bb1b66b3-19b9-480e-af0b-f06f8de0d930)